Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Hartman

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Lancet. Global Health|June 14, 2024
Global health for rare diseases through primary careGareth Baynam, Adam L Hartman, Mary Catherine V Letinturier, et al.
Annals of Neurology|December 26, 2015
Response to treatment in a prospective national infantile spasms cohortKelly G Knupp, Jason Coryell, Katherine C Nickels, et al.
Neurology|February 10, 2017
Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticusMackenzie C Cervenka, Sara Hocker, Matthew Koenig, et al.
European Journal of Medical Genetics|October 7, 2024
Telehealth for rare disease care, research, and education across the globe: A review of the literature by the IRDiRC telehealth task forceFaye H Chen, Adam L Hartman, Mary Catherine V Letinturier, et al.
Therapeutic Advances in Rare Disease|March 26, 2026
Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews by the IRDiRC telehealth task forceMelissa A Parisi, Adam L Hartman, Mary Catherine V Letinturier, et al.
Epilepsia|September 13, 2016
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohortKelly G Knupp, Erin Leister, Jason Coryell, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
GM1 Gangliosidosis Type II: Results of a 10-Year Prospective StudyPrecilla D'Souza, Cristan Farmer, Jean Johnston, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 20, 2024
GM1 gangliosidosis type II: Results of a 10-year prospective studyPrecilla D'Souza, Cristan Farmer, Jean M Johnston, et al.
The New England Journal of Medicine|January 16, 2020
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm InfantsSandra E Juul, Bryan A Comstock, Rajan Wadhawan, et al.
Annals of Neurology|October 9, 2018
KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defectKyle A Metz, Xinchen Teng, Isabelle Coppens, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Lancet. Global Health|June 14, 2024
Global health for rare diseases through primary careGareth Baynam, Adam L Hartman, Mary Catherine V Letinturier, et al.
Annals of Neurology|December 26, 2015
Response to treatment in a prospective national infantile spasms cohortKelly G Knupp, Jason Coryell, Katherine C Nickels, et al.
Neurology|February 10, 2017
Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticusMackenzie C Cervenka, Sara Hocker, Matthew Koenig, et al.
European Journal of Medical Genetics|October 7, 2024
Telehealth for rare disease care, research, and education across the globe: A review of the literature by the IRDiRC telehealth task forceFaye H Chen, Adam L Hartman, Mary Catherine V Letinturier, et al.
Therapeutic Advances in Rare Disease|March 26, 2026
Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews by the IRDiRC telehealth task forceMelissa A Parisi, Adam L Hartman, Mary Catherine V Letinturier, et al.
Epilepsia|September 13, 2016
Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohortKelly G Knupp, Erin Leister, Jason Coryell, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
GM1 Gangliosidosis Type II: Results of a 10-Year Prospective StudyPrecilla D'Souza, Cristan Farmer, Jean Johnston, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 20, 2024
GM1 gangliosidosis type II: Results of a 10-year prospective studyPrecilla D'Souza, Cristan Farmer, Jean M Johnston, et al.
The New England Journal of Medicine|January 16, 2020
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm InfantsSandra E Juul, Bryan A Comstock, Rajan Wadhawan, et al.
Annals of Neurology|October 9, 2018
KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defectKyle A Metz, Xinchen Teng, Isabelle Coppens, et al.
Pageof 9